Dr. Ing. h.c. F. Porsche AG (VIE:P911)

Market Cap	38.92B
Revenue (ttm)	38.78B
Net Income (ttm)	2.16B
Shares Out	n/a
EPS (ttm)	2.37
PE Ratio	17.99
Forward PE	19.78
Dividend	2.31 (5.34%)
Ex-Dividend Date	May 22, 2025

Volume	408
Average Volume	1,518
Open	43.24
Previous Close	42.57
Day's Range	43.24 - 43.53
52-Week Range	39.65 - 74.70
Beta	n/a
RSI	47.24
Earnings Date	Jul 30, 2025

About Verve Therapeutics

Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company develops, manufactures, and sells vehicles. It also offers customer and dealer financing, leasing, and mobility and other finance-related services. The company was formerly known as Porsche Fünfte Vermögensverwaltung AG and changed its name to Dr. Ing. h.c. F. Porsche AG in November 2009. The company was incorporated in 2009 and is headquartered in Stuttgart, Germany. Dr. Ing. h.c. F. Porsc...

• Industry: Motor Vehicles and Passenger Car Bodies
• Founded: 2009
• Employees: 42,615
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: P911

Financial Performance

In 2024, VIE:P911's revenue was 40.08 billion, a decrease of -1.10% compared to the previous year's 40.53 billion. Earnings were 3.59 billion, a decrease of -30.35%.